Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gland Pharma has informed that the Management of the Company is participating in an Investor Conference scheduled to be held in Mumbai on September 27, 2023. The Management will interact with the investors during the Investor Conference. Details enclosed.
The above information is a part of company’s filings submitted to BSE.